• Blog
  • Pricing
  • Contact
  • FAQ
Sign InSign Up
AI Agent for Financial MarketsAsk anything. Our AI Agent brings real-time data and full market coverage.Open chat
MarketsStocksCryptoForexCommoditiesCalendarInsiders
FLXN

FLXN

Horizon Flexible Income ETF

CBOEFinancial ServicesAsset Management - BondsUS

USD24.94

-0.09 (-0.35%)

Company Profile

IPO Date

2025-07-03

Sector

Financial Services

Industry

Asset Management - Bonds

Exchange

CBOE

Country

US

Market Metrics

Open

$24.99

Prev. Close

$25.03

Day Low

$24.93

Day High

$24.99

52W Low

$24.76

52W High

$26.09

Market Cap

$0.00B

Volume

0.00M

OverviewFinancialsRatingsInsidersSentimentsChart Patterns
News SentimentBullish

Articles

10

Avg Positive

21.8%

Avg Negative

4.9%

Avg Neutral

73.3%

News Feed

Flexion Therapeutics to Report Second-Quarter 2021 Financial Results on August 4, 2021

GlobeNewsWire·7/29/2021·↓ negative

Flexion Therapeutics: Sector Sell-Off Provides Opportunity To Reload At A Discount

Seeking Alpha·7/22/2021·↑ positive

Flexion Therapeutics Announces Appointment of Utpal Koppikar to its Board of Directors

GlobeNewsWire·
7/12/2021
·↑ positive

Flexion Therapeutics to Present at the 2021 Raymond James Human Health Innovation Conference

GlobeNewsWire·6/14/2021·↑ positive

Flexion Therapeutics Announces Appointment of William T. Andrews, M.D.

GlobeNewsWire·6/9/2021·↑ positive

Flexion Therapeutics to Present at the Goldman Sachs 42nd Annual Global Healthcare Virtual Conference

GlobeNewsWire·6/2/2021·↑ positive

Flexion Therapeutics to Present at the RBC Capital Markets 2021 Virtual Global Healthcare Conference

GlobeNewsWire·5/13/2021·↑ positive

Flexion Therapeutics, Inc. (FLXN) CEO Michael Clayman on Q1 2021 Results - Earnings Call Transcript

Seeking Alpha·5/12/2021·↓ negative

Flexion Therapeutics: Q1 Earnings Insights

Benzinga·5/12/2021·↑ positive

Earnings Preview: Flexion Therapeutics

Benzinga·5/11/2021·↓ negative